Introduction
The magnitude and profile of immune responses are regulated to a large extent by cytokines. The extent to which cytokines are secreted varies between individuals with consequent variations in the intensity of a given immune response. Several regulatory genetic elements associated with differences in secretion have recently been identified in the genes coding for a number of different cytokines. [1] [2] [3] [4] [5] [6] These regulatory polymorphisms are therefore thought to be at least partially responsible for interindividual differences in their ability to cope with a given challenge to the immune system. Different cytokine genotypes directly reflect high-and low-responsive cytokine promoters. [1] [2] [3] 7, 8 There can be up to 20-fold differences between the highest and lowest cytokine production levels measured after in vitro stimulation. The precise composition of mosaics of promoter elements reflecting high and low responses however is still unknown. Specific cytokine genotypes may be beneficial by creating a 'proinflammatory' phenotype, that may nevertheless predispose to chronic inflammatory diseases or to a more severe form of inflammatory disease with a worse clinical outcome.
Interleukin 10 (IL-10) is an important immunoregulatory cytokine in man. 9 The gene of IL-10 has been mapped within a cluster of gene homologues to human chromosome 1, between 1q31 and 1q32. 10, 11 Interindividual differences in the expression of IL-10 thus also may affect the modulation of the expression of other key cytokines involved in the immune response. Variable associations between IL-10 production and either the proximal IL10.G microsatellite alleles, single-nucleotide polymorphisms (SNP) or SNP haplotypes in the 1.4 kb IL-10 proximal promoter region have been reported. [1] [2] [3] 12 Several studies have reported associations between IL-10 promoter polymorphisms and risk of a diverse range of diseases including (for example) asthma, systemic lupus erythematosus and rheumatoid arthritis, infectious diseases as well as transplantation complications. [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] These results, coupled with recent data indicating a relationship between distal haplotypes in the same region and IL-10 production have raised the possibility that other more distal promoter elements may affect IL-10 production.
Recent characterisation of the 5 0 -flanking region of the IL-10 gene has shown positive and negative regulatory elements. 2, 10, [26] [27] [28] [29] [30] [31] [32] However, promoter elements possibly involved in IL-10 regulation in subsets of cell lines may not accurately reflect the interindividual differences in IL-10 expression found in in vitro stimulated human peripheral blood mononuclear cells (PBMC).
IL-10 secretion following in vitro stimulation of PBMC with LPS or Concanavalin-A varies markedly between individuals. [1] [2] [3] The haplotype -1087/À824/À597 GCC was defined as IL-10 high-responsive. More distal SNP have been shown to be associated with high and low IL-10 production and found to sustain the hypothesis of a cooperation of elements within the IL-10 promoter. 2 The À3538/À2736 AA haplotype seems to be related to low IL-10 production. The extended -1354/À1087/À824/ À597 AGCC haplotype perhaps surprisingly remains in the low producer range. 2 But when the more distal haplotype À3538/À2736 TC was analysed for linkage with the haplotype -1354/-1087/À824/À597 AGCC no relation to a low or high producer phenotype was observed. This indicates that the mosaic of IL-10 promoter elements reflecting high and low responses is still incompletely defined.
In the current study, we have addressed two issues. First, the relationship of new distal gene variations within the 5 0 -flanking region of the IL-10 gene with other polymorphisms that might affect IL-10 production, since the -6208 SNP is conserved in different populations suggesting an evolutionary conservation and implying a functional role. Second, the impact of the pathways of induction of IL-10 on interindividual differences in IL-10 secretion. In order to answer these questions, we report here the first in a series of studies of genetic variations aimed at analysing the IL-10 production capacity of PBMC using in vitro assays comprising dibutyryl-cAMP (db-cAMP) -or LPS-stimulation of PBMC as well as Epstein-Barr virus-immortalised B cells to gain more insight into the relationship between several SNPs and microsatellites.
Our data show that the definitions of IL-10 high-or low-producer haplotypes used to date are mainly derived from stimulation with LPS or related agents. This has to be taken into account when allelic or genotypic data from patient samples are classified as low-or high producer in this way without knowledge of the agent responsible for deregulated IL-10 expression.
Results

Phenotypic characterisation of healthy Caucasian blood donors
To define the association of certain SNP-mosaics with the capacity of PBMC to produce IL-10, PBMC from healthy Caucasian blood donors (Germany/Stuttgart) were isolated by Ficoll separation and stimulated in vitro with db-cAMP or LPS. Both reagents were used because it is already known that there are interindividual differences for LPS-dependent IL-10 expression and that the IL-10 promoter is regulated in a cAMP-dependent manner. In addition, PBMC were immortalised in vitro by infection with EBV. The amount of IL-10 produced within 24 h by these immortalised B cells was analysed 4-6 weeks after infection.
The amount of IL-10 varies between 8 and 7652 pg/ml after LPS stimulation (median 807 pg/ml; interquartile range 322-1690 pg/ml) and between 8 and 523 pg/ml after stimulation by db-cAMP (median 121 pg/ml; interquartile range 32-231 pg/ml). EBV-immortalised B lymphocytes (lymphoblastoid cell line (LCL)) vary in their expression of IL-10 between 23 and 2770 pg/ml (median 389 pg/ml; interquartile range 177-1059 pg/ml). Thus, the range of interindividual differences in the IL-10 production capacity differs according to the pathway of induction of IL-10 expression, where LPS stimulation was associated with the highest amount of IL-10, and dbcAMP stimulation was found to be less effective.
The DNA of volunteers are genotyped by the recently described multiplex-PCR introducing corresponding primer pairs of the -1087AG and -824CT gene variations. 33 Determination of new distal haplotypes of the 5 0 -flanking region of the IL-10 gene To determine first the distal IL-10 promoter haplotypes for the SNPs -6208 C/G and -6752 A/T a cohort of 204 Caucasian donors was genotyped by multiplex-PCR. Considering the distal haplotype comprising the SNPs -6752 A/T and -6208 C/G three major haplotypes TC, AG and AC were observed ( Table 1 ). The haplotype TG was rarely found. Including the -3538 A/T gene variation major extended distal haplotypes could be identified: AGT, TCA and ACT which were present with the highest frequency ( Table 1) .
In an African population (Table 1) , the SNPs -6752 A/ T and -6208 C/G showed the same three major haplotypes TC, AG and AC as seen in Europeans. Including the SNP À3538 A/T similiar major haplotypes were identified: AGT, TCA and ACT (Table 1) . In a third, independent population from Vietnam (Asia) the distal haplotype AG (-6752 A/T and -6208 C/G) was present at a frequency of 95% as well as the extended distal haplotype AGT (Table 1) . 0 -flanking region of the IL-10 gene might be related to differences in IL-10 production, healthy blood donors previously phenotyped as high or low producer of IL-10 were examined.
After stimulation with LPS it was found that the À6752/À6208 TC-haplotype was characterised by higher IL-10 expression (median IL-10 release: 980 pg/ml), whereas the AG-haplotype was associated with lower IL-10 response (698 pg/ml) ( Table 2 ). The AC-haplotype was intermediate (885 pg/ml) ( Table 2 ). These data showed no statistically significant differences (Po0.13), but showed the same trend as the allelic analysis where the T allele of the SNP À6752 and the C allele of the SNP À6208 are associated with higher IL-10 production (Table 3) . Stimulation with db-cAMP did not reveal any differences (P ¼ 0.4) ( Table 3 ). Significant differences in IL-10 production were found in LCLs with respect to the corresponding haplotypes (Table 2 ). In EBV-immortalised B lymphocytes the TC-haplotype is characterised by higher IL-10 production (461 pg/ml), whereas the AGhaplotype was related to a lower level of IL-10 (379 pg/ ml), and the AC-haplotype to the lowest amount of IL-10 with a median of 192 pg/ml (Po0.026) ( Table 2 ).The IL-10 production associated with the AC haplotype was significantly lower when compared to all other haplotypes (Po0.01), although the low number of AC alleles has to be taken into account.
Genotypic analysis for these two distal SNPs showed no significant interindividual differences in IL-10 production for either stimulant, or for immortalisation with EBV.
For the haplotype -6752/À6208/-3538 the following results for IL-10 secretion were found: after LPSstimulation the relationship of IL-10 release and haplotypes showed a significant different expression pattern (P ¼ 0.03) ( Table 3 ). The haplotype ACT was found to be related to the highest median IL-10 secretion (2015 pg/ ml); ACA to the lowest IL-10 response (435 pg/ml). Thus, the -3538 gene variation appears to affect the capacity to Shown are the median amounts of IL-10 in pg/ml in the supernatant of stimulated cells 24 h after stimulation as well as the semi-interquartile ranges (in small italic). P, corresponding P-values; N, number of analysed individuals. Shown are the median amounts of IL-10 in pg/ml in the supernatant of stimulated cells 24 h after stimulation as well as the semi-interquartile ranges (in small italic). P, corresponding P-values; N, number of analysed individuals.
express IL-10 after LPS stimulation when linked to the haplotype À6752/À6208 AC. Segregation of db-cAMPstimulated cells with respect to the haplotypes mentioned above revealed no difference in IL-10 production (Table 3) . For LCLs the haplotype ACA tended to be related to low IL-10 expression, whereas the difference between the other haplotypes with respect to IL-10 were small. The low number of individuals with the ACA haplotype makes interpretation of these data difficult. Analysis of the genotypes for the SNPs -6752/-6208 and -3538 revealed no significant differences for either LPS or cAMP stimulation or for EBV-associated IL-10 expression (data not shown).
Extended SNP haplotypes of the 5
0 -flanking region of the IL-10 gene Previous work has suggested that there is an association of proximal SNPs and haplotypes with IL-10 production capacity.
1-3,31 Therefore, we considered the possibility that an extended SNP haplotype might show a stronger relationship with IL-10 production than the recently described SNP haplotype alone or that it is possible to define subgroups with a much stronger differentiation into low and high IL-10 responder. To test this hypothesis, we describe extended haplotypes based on analysis of genotypes in homozygous donors or donors with a single heterozygous site (Figure 1) . Taken together the proximal haplotype GCC (À1087, À824 and -597) is linked to a higher degree to various different distal haplotypes, whereas the proximal haplotypes ATA or ACC are found almost exclusively in combination with the distal haplotype AGTCG (Figure 1 ). In contrast, the high producer haplotype GCC shows a more diverse linkage including nine different haplotypes with a preference for the distal TCA haplotype, which comprises the high producer alleles shown above. The investigation of the IL-10 expression profile in relation to these extended haplotypes, however, did not show significant associations to the amount of IL-10 produced in our assays, when homozygotic carriers of corresponding haplotypes were compared with heterozygotes (data not shown). Table 5 shows the haplotypes formed by the SNP À6572, À6208, À3538, À1354, À1087 and -597 to allow comparison of different geographical populations. In the African population, the extended SNP haplotype was found to be more variable when compared to the cohort from Germany as well as to that from Vietnam. The haplotype AGTGAA was predominant in the Asian and African groups (74 and 28%, respectively), whereas in the Caucasian group the haplotype TCAAGC was most frequent (33%). The haplotypes TGTGAA, TCAGAC, TCAGGC, ACTAAC and AGAAGC were found only in the African study group, whereas the haplotype TCAAAC was found only in the German study group and TCTAGC in the Vietnamese group (Table 4) .
The SNP -1087A/G is related to different IL-10 production after LPS-stimulation The allele -1087A has been described as reflecting IL-10 low responses following Concanavalin-A and LPS stimulation.
2,3,31 LPS-dependent IL-10-secretion varies in our assay also according to the alleles of the SNP: the A allele was associated with a median IL-10 secretion Included are also the proximal SNPs at À1087 and À597. N, number of analysed individuals.
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Mosaics gene variations IL10 production M Mörmann et al level of 681 pg/ml; the G allele was associated with a median IL-10-release of 980 pg/ml (Figure 2c ). No such effects were observed in the db-cAMP-stimulated PBMCs, where the median amounts of IL-10 showed no such differences (allele A: 103 pg/ml; allele G: 134 pg/ml) ( Figure 2a ). After immortalisation with EBV IL-10 secretion of these B lymphocytes also varied according to alleles (allele A: 466 pg/ml and allele G: 390 pg/ml) ( Figure 2e) . However, the differences in IL-10 production were significant only in LPS-stimulated samples (Po0.05).
In addition, we assessed the relationship of corresponding homozygotes with low or high IL-10 expression after stimulation by LPS, db-cAMP or EBV reflecting the same association as found for the allelic analysis.
The haplotype -1087/IL10.G. in relation to IL-10 in vitro responses Within the recently described multiplex assay, we introduced a modification allowing to identify directly the association of -1087A/G gene variations with corresponding IL10.G alleles located directly 5' from this gene locus and compare this haplotype with differentially regulated IL-10 expression (Figure 3 ) (Table 5) . 33 In combination with our in vitro stimulation assay two striking observations can be made: first, that the alleles IL10.G10, G12 and G14 (22, 24 and 26 dinucleotide repeats, respectively) are related to higher amounts of IL-10 after LPS stimulation compared to all other haplotypes ( Figure 3) . Second, the influence of the alleles A or G of the SNP -1087 is also evident when analysed as a haplotype with the microsatellite IL10.G (Figure 3a) . The -1087G allele linked with IL10.G is related to higher IL-10 production. Only for the allele IL10.G13 (25 dinucleotide repeats) the observed influence of the allele A or G was marginal suggesting a low producer function for the allele IL10.G13 alone (IL10.G13/-1087A: 494 pg/ml; IL10.G13/-1087G: 557 pg/ml). The relationship of the IL10.G10 allele (22 dinucleotide repeats) with the highest amount of IL-10 released by the cells was also found for LCLs (Figure 3b) , although the influence of the A and G alleles was not so consistent as after stimulation with LPS. This may indicate a different influence of the microsatellite on the -1087 gene variation in its effect on IL-10 transcription modulation supporting the hypothesis of the existence of specific mosaic reflecting the modulatory capacity of certain genetic elements within the 5'-flanking region of the IL-10 gene. In contrast to LPS stimulated PBMC and LCLs the stimulation of PBMC by db-cAMP was found to be completely different in that the haplotype IL10.G10/-1087G is not characterised by a high IL-10 production capacity, although the observed interindividual differences were not statistically significant.
The microsatellite IL10.R in relation to IL-10 in vitro responses
The in vitro IL-10 responses after db-cAMP or LPS stimulation of PBMC or in LCLs in relation to the length of IL10.R CA-dinucleotide repeats were compared. For both microsatellites, we found differences in IL-10 levels in relation to the corresponding alleles of IL10.G and IL10.R after LPS-and db-cAMP-stimulation and transformation with EBV, but only significant differences were observed for the microsatellite IL10.R. Analysis of the association between the allelic distribution of IL10.R and LPS-or EBVmediated IL-10-secretion are displayed in Figure 4 .
Comparison of the alleles of IL10.R and the corresponding IL-10 secretion showed significant differences in LPS-mediated IL-10 release in relation to the length of this CA-dinucleotide repeat (Po0.007). Furthermore, the median amount of IL-10 increases with every additional CA-repeat (allele IL10.R2 (13 CA-dinucleotid repeats): 579 pg/ml; allele IL10.R3: 1073 pg/ml and allele IL10.R4: 1554 pg/ml). For db-cAMP-dependent IL-10 secretion no such association was found. Here, the amounts of IL-10 did not differ (allele R2: 113 pg/ml, allele R3: 132 pg/ml and allele R4: 112 pg/ml IL-10). After immortalisation with EBV IL-10 secretion showed a significant dependence on the alleles of IL10.R with a median IL-10 response of 377 pg/ml for R2, 470 pg/ml for R3 and 196 pg/ml for R4 (Po0.038).
For the genotypes of IL10.R the same pattern of association after LPS-stimulation is evident: a significant (Po0.002) increase in cytokine release with every additional CA-repeat (R13/13: 546 pg/ml. R13/14: 735 pg/ml and R14/14: 1690 pg/ml). For the corresponding genotypes, no significant differences were observed for either db-cAMP-stimulated cells or for LCLs.
Discussion
In order to answer the questions (first) if the recently discovered distal SNPs of the 5 0 -flanking region of the IL-10 gene are part of a mosaic affecting interindividual differences in IL-10 production capacity, DNAs from healthy donors were genotyped for the microsatellites IL10. G and IL10.R and for the SNPs -597 AC, À824 CT, À1087 AG, À1354 AG, À2736 AC, À3538 AT, À6208 CG and À6752 AT and combined with an in vitro stimulation assay. As a second question the impact of the pathways regulating IL-10 expression on interindividual differences in IL-10 secretion was analysed by comparing dbcAMP-or LPS-stimulation as well as immortalisation of B cells by EBV with corresponding genetic data. From these experiments, we wanted to gain more insight into the relationship of the genetic structure of IL-10 and their functional effects. The genetic analysis described here provides substantial new evidence for haplotypes related to low or high producer phenotypes. Furthermore, the comparison of different stimuli adds several new elements into this mosaic of promoter elements reflecting high and low IL-10 responsiveness.
The haplotype analysis revealed six major haplotypes that have a population frequency of at least 2% (Figure 1 ). Looking at all the haplotypes found in the analysed Caucasians two major observations can be stated: the Mosaics gene variations IL10 production M Mörmann et al proximal low producer haplotypes -1087/-824/-597 ATA and ACC are almost exclusively linked to the distal haplotype AGTCG (SNPs 6752/À6208/À3538/À2736/ À1354), whereas the proximal high producer haplotype GCC is linked in (about) 58% of cases distal to TCAAA. The number of other distal haplotypes linked to GCC is higher compared to ATA or ACC suggesting a higher potential for variable effects on IL-10 expression.
Comparison of the haplotypes -6752/À6208/À3538/ À1354/À1087/À597 (Table 4) revealed different geographic distributions in the African, Asian and Caucasian cohorts. The African population shows a more widespread distribution of haplotypes than the Caucasian population, whereas the haplotypes from the cohort from Vietnam were more restricted. As shown previously the allelic and genotypic comparison of Caucasians (Germany) and Africans (Gabon) revealed no significant differences for the SNPs -1087 and -6208. This may hint at the importance of these two SNPs and their haplotypes for the regulation of IL-10, since these loci are evolutionarily young and therefore not altered by mutation or recombination. In contrast to these results, we found in the cohort from Vietnam the allele A at position -1087 dominant and at -6208 the allele G which is probably the result of different environmental ecological conditions.
Further evidence for the importance of the SNP -6208 in the regulation of IL-10 can be drawn from the consideration of the distal haplotypes comprising the SNPs -6752/À6208/À3538. After LPS-stimulation the haplotype ACT could be defined as a high producer whereas the haplotype ACA was related to the lowest cytokine level suggesting that T at -3538 relates this haplotype to high IL-10 release (Table 3) . However, a G at -6208 may partially neutralise this effect. The absence of comparable relationships between haplotypes and IL-10 expression after stimulation by db-cAMP or IL-10 expression as a result of EBV immortalisation is a clear indication that the description of low-or high-producer haplotypes strongly depends on the pathway of IL-10 expression that is activated.
In addition, LPS-stimulated samples served as an internal control to allow a comparison with published data, although differences related to sample handling or assay performance cannot be excluded. On description of a comparable relationship between the biallelic gene variation at -1087 and the amount of IL-10 produced after LPS stimulation, as shown in Figure 2 thus adds strength to the interpretation of our findings relating to the distal haplotypes. In addition, the investigation of this gene locus showed that the definition of low-or high-producer alleles/genotypes as stated above must be performed with caution. The results with EBV-immortalised B lymphocytes suggest that in the case of intracellular infectious agents that affect IL-10 expression the well known LPS-related low-and high-producer classification may fail to account for described interindividual differences in IL-10 secretion. This is an important finding, which has to be taken into acount when allelic or genotypic data of disease samples are classified in this way without knowing the agent responsible for deregulated IL-10 expression. In addition, this divergent mosaic of gene variations differentially affecting IL-10 expression mediated by different haplotypes will impact on the design of targeted immunotherapeutic strategies. This supports the idea that specific transcriptional elements through which different agents regulate IL-10 promoter activity are differentially susceptible to modulation by gene variations.
Platzer et al showed several functional cAMP responsive elements (CRE) within the proximal 5 0 -flanking region of the IL-10 gene. However, these CRE-sites are only partially involved in cAMP-dependent IL-10 promoter regulation, because a C/EBP site around the initiation site of transcription plays a dominant role. 34 However for db-cAMP, no significant associations were found with respect to the gene polymorphisms detected. This indicates that the known promoter elements are not affected in their regulatory potential by the gene variations described here. In contrast, the -1087 gene variation that most strongly reflects interindividual variations in LPS-associated IL-10 expression may discriminate binding of PU.1, an ets-transcription factor. 35 However, it is technically difficult to discriminate this genetic variable site from the genetic invariable site directly 3 0 from the SNP in terms of ets-binding.
The conclusion about the divergent mosaic of gene variations differentially affecting IL-10 expression applies also to analysis of the IL10.R microsatellite. In a recent report, it was shown that IL-10 secretion after LPS stimulation varies according to the genetic composition of the IL-10 gene locus, that is, the number of CA repeats of the two microsatellites. 1 The results found by Eskdale and co-workers showed that the genotypes containing the allele IL10.R with 14 CA-dinucleotide repeats is related to the lowest IL-10 secretion after LPS-stimulation. In our hands, this genotype showed a median IL-10 expression capacity with all stimulants and a significant difference for LPS-stimulation. This, however, may result from the use of different in vitro stimulation assays as well as different frequencies of detected genotypes (homozygotes with 13 CA-repeats nÀ49/35; homozygotes with 14 CA-repeats n ¼ 11/14; heterozygotes n ¼ 39/30 (our study / published data respectively)). 1 Having analysed for the first time the relationship between IL-10 release and haplotypes composed of the IL10.G microsatellite and the biallelic gene variation at -1087, two striking observations were made: the alleles IL10.G10, G12 and G14 are related to higher amounts of IL-10 compared to all other haplotypes when found in combination with -1087G (Figure 3 ). These differences were significant for LPS-stimulated PBMC. In EBVimmortalised B lymphocytes the sample size was probably too small to reveal such a profile. Second, in LPS-stimulated samples the influence of the A and G alleles of the SNP -1087 is similar when analysed as a haplotype in combination with the microsatellite IL10.G as shown in Figure 3 : the combination of the -1087G allele with IL10.G is mainly related to higher IL-10 production compared to the A allele. However, the influence of these alleles was not so consistent in LCLs or db-cAMP-stimulated leukocytes. This may indicate a different influence of the microsatellite on the -1087 gene variation in its effect on IL-10 transcription modulation.
In conclusion, we present a comparative analysis of the IL-10 gene locus where peripheral blood leukocytes were stimulated in in vitro assays with db-cAMP, LPS or were immortalised by Epstein-Barr virus. Significant differences were observed mainly with LPS-stimulated leukocytes or LCLs for IL-10-secretion in relation to the alleles of the microsatellite IL10.R, IL10.G linked with the SNP -1087AG as well as with distal and proximal haplotypes defining different low and high responder mosaics. It is clear that differences in cytokine release depend on the stimulant used. This study provides further evidence that different genetic structuresmicrosatellite as well as SNP -affect the expression of IL-10. In addition, we have been able to show that different stimuli have different effects on the amount of secreted IL-10 in relation to certain alleles and genotypes of the genetic loci investigated. The association between known gene variations and IL-10 production is not absolute suggesting that additional factors related to the observed mosaic must underlie the tight genetic control of this cytokine production levels.
Our data show that definitions of IL-10 high-or lowproducer haplotypes use to date are mainly restricted to situations where LPS or related agents were used and that genotyping in clinical studies demonstrating prevalences of one or another allele have to be interpreted with some degree of caution. Our data present a step forward in the understanding of the complex mosaic of genetic variations of cytokines, affecting genetic susceptibility and pathogenesis of many diseases where IL-10 is deregulated.
Materials and methods
Blood samples and DNA isolation
The 203 DNA samples used in the study were isolated from buffy coats obtained from the blood donation centre of Stuttgart, Germany as described previously. 33 DNA probes from healthy African or Vietnamese volunteers were isolated by the same procedure and were described previously.
36,37
Peripheral blood mononuclear cells, cell culture and cell stimulation PBMC were isolated from buffy coats using Ficoll separating solution (Pharmacia Biotech, Freiburg, Germany). The isolated PBMCs were counted and resuspended in RPMI 1640 cell culture medium (Sigma) with addition of 1% Penicillin, Streptomycin, Glutamine (Sigma), 10% FCS (Sigma) and cultured in 24-well cell culture plates (Costar, Corning New York, USA) for 24 h at 371C and 5% CO 2 , at a concentration of 1 Â 10 6 cells/ ml. Cells were centrifuged at 2200 U/min for 10 min at 41C. The supernatants were taken and frozen at -801C. The cells were stimulated either with db-cAMP (Sigma) at 1 mM or with LPS (Lipopolysaccharide from E. coli 055:B5) (Sigma) at 1 mg/ml.
Immortalisation of PBMC with Epstein-Barr virus
The marmoset-cell line B95-8 was cultured to a density of 10 6 cells/ml over 3 days in the same media as stated above for PBMC for 3 days. Cells were centrifuged at 6000 g and supernatant containing EBV was used for in vitro infection of B lymphocytes. 1 Â 10 7 PBMCs were incubated with 1 ml of EBV-containing supernatant for 1 h at 371C. PBMC were collected and grown for 7 days at 371C and 5% CO 2 in complete RPMI 1640 cell culture medium at a concentration of 10 6 cells/ml. Lymphoblastoid cells were expanded for additional 2 weeks and analysed three times 4-6 weeks after infection for the amount of IL-10 produced within 24 h.
Cytokine measurement by ELISA
The concentration of human IL-10 in the cell supernatants was measured by Enzyme-linked immunosorbent assay (ELISA) (IL-10 Eli-pair, Trinova Biochem GmbH, Giessen, Germany) according to the manufacturer's instructions. The ELISA was performed in 96-well plates (Nunc, Wiesbaden, Germany). The IL-10 concentration was estimated photometrically with Mikrowin software running a DigiScan ELISA-Reader (Asys Hightech) at 450 nm wavelength.
Multiplex-PCR, electrophoresis and fragment analysis
For the analysis of the genetic polymorphisms of the IL-10 promoter a modified mulitplex-assay was used as described recently. 33 Briefly the modifications were as following instead of primers to detect IL10.G microsatellites a set of fluorescence-labelled primers with corresponding allele mismatches at the 3 0 -ends for the SNP -1087A/G were used allowing the simultaneous detection of SNP and microsatellite lengths. In addition, we introduced primers to analyse gene variations at À824C/T and -2736C/G. The primers used were described recently, newly designed primers are shown in Table 6 . 33, 37 Genetic data were analysed using GENEPOP software. 38 Analysis included tests for Hardy-Weinberg equilibrium, genotypic and allelic differentation between the two groups as well as for the data of expected vs TACCCTTGTACAGGTGATGTAAC  FAM  IL-10-824T  TACCCTTGTACAGGTGATGTAAT  HEX  IL-10 824  TAGTCTGCACTTGCTGAAAGCTT  -IL-10-1087A  CTTACCTTCCCTACTTCCGCT  FAM  IL-10-1087G  CTTACCTTCCCTACTTCCGCC  HEX  IL-10-1087  GTTTCTGTCAACACTCCTCGCCGCAACCCA  -IL-10-2736A  GCGCCTGGCACCACGCCCGTCTAAT  FAM  IL-10-2736C  GCGCCTGGCACCACGCCCGTCTAAG  HEX  IL-10-2736 GTTTCTGGGTCCCTTACTTTCCTCTTACCTATCC -All other oligonucleotides used in this study were described recently. 33 observed homo-and heterozygous individuals. Haplotype analysis was performed using Arlequin software and http://www.bioinf.mdc-berlin.de/projects/hap/. 39 
